As many know, amniocentesis is a prenatal screening procedure often recommended for older expectant mothers. However, many mothers-to-be worry this test may harm the fetus.
What can amniocentesis detect?
Thalassemia
Amniocentesis can confirm whether the fetus has severe thalassemia;This condition involves not an entire chromosome defect but large deletions in specific chromosomal segments, which can be detected through genetic analysis of amniotic fluid.
Fetal Blood Type and Gender
Amniotic fluid can be tested for blood type to screen for severe fetal anemia. Early detection allows for in-utero treatment. It can also determine fetal gender, though fetal gender determination without medical indication is not permitted.

Fetal Developmental Disorders
Amniotic fluid can be analyzed using genetic microarrays to diagnose rare, difficult-to-explain fetal malformations, severe developmental disorders, or intellectual disabilities.
Diagnosis of Intrauterine Infections
Amniotic fluid can also diagnose specific intrauterine infections like rubella virus, cytomegalovirus, or toxoplasmosis, which may cause severe intellectual disabilities, deformities, or developmental delays in the fetus.
Paternity Testing
Paternity testing via amniotic fluid is relatively safe. This procedure analyzes short tandem repeats (STRs) by comparing fetal DNA fragments with parental DNA to determine paternity.
When is amniocentesis necessary?
Advanced maternal age
Amniocentesis is recommended for patients requiring prenatal diagnosis, including those at high risk for Down syndrome. Pregnant women over 35 years old reach a 1 in 300 risk threshold for Down syndrome, making amniotic fluid testing advisable for older mothers.All pregnant women undergo Down syndrome screening during prenatal checkups. If screening results exceed a 1 in 250 risk threshold, prenatal diagnosis is recommended.
Familial Genetic Disease: Thalassemia
Familial genetic disease thalassemia requires amniocentesis if both parents are carriers of the same thalassemia trait to determine if the child has severe thalassemia. It is also indicated if the mother has Rh-negative blood and there is suspicion of potential Rh incompatibility hemolysis in the fetus.
Prenatal diagnosis is required for severe fetal abnormalities
If severe cardiac malformations, intestinal obstruction, or urinary tract hydronephrosis are detected via imaging (e.g., ultrasound) during pregnancy, prenatal diagnosis is necessary to rule out chromosomal abnormalities. If these anomalies occur without chromosomal abnormalities, surgical correction may be possible after birth.
Is amniocentesis a good option?
Amniocentesis is the most widely used prenatal diagnostic method, typically performed between 17 and 23 weeks of gestation.Prenatal diagnosis can utilize three types of samples: chorionic villi, amniotic fluid, or umbilical cord blood. Chorionic villus sampling is performed between 11 and 13 weeks 6 days of pregnancy, carries higher risks, with bleeding or miscarriage rates reaching 2%. Umbilical cord blood sampling is suitable for pregnant women who have missed the windows for amniocentesis or chorionic villus sampling, typically performed after 24 weeks of pregnancy. The optimal time for amniocentesis is between 17 and 23 weeks of pregnancy.Before 17 weeks, fetal amniotic fluid is limited, and amniocentesis carries greater risks to the fetus. Additionally, fetal cell shedding is minimal before 17 weeks. After 24 weeks, fetal epidermal cells undergo keratinization, reducing the success rate of culturing keratinized cells.
Amniotic fluid test results are over 99% reliable
Amniocentesis results are highly reliable at nearly 99%. Reports are interpreted with great caution: a standard test requires counting 20 to 50 cells, with each cell's karyotype meticulously examined. However, the cell culture process may be compromised, potentially preventing cell growth. In such cases, umbilical cord blood sampling may be necessary for confirmation.
What should be considered before amniocentesis?
Confirm indications for the procedure and screen for syphilis, HIV, etc.
Preoperative verification includes: First, confirming indications—whether the patient is at high risk for Down syndrome.Second, determine if the mother has syphilis, HIV, or hepatitis, as these diseases could be introduced into the uterine cavity during the procedure, causing secondary infections. According to current international practice, HIV-positive individuals should minimize invasive procedures, and active syphilis should also preclude amniocentesis.
Pre-procedure exclusion of infection, uterine contractions, and bleeding Breakfast is permitted before amniocentesis.Upon arrival at the hospital, the patient's temperature is taken to rule out infection. The presence of significant uterine contractions or bleeding is assessed. If contractions or bleeding occur, the procedure cannot proceed. If no such issues are present, an ultrasound is performed to evaluate the baby's condition, the position of the placenta, and the fetus. The puncture site is selected in an area where the amniotic fluid is relatively deep, avoiding the placenta.>Preoperative ultrasound to determine placental position
A routine ultrasound is performed before the procedure to confirm placental location. This helps identify if the placenta is low-lying or predominantly positioned on the anterior uterine wall, which could obstruct the surgical view. These factors must be assessed beforehand. Amniocentesis is crucial for many twin prenatal diagnoses. Blind procedures risk puncturing the same amniotic cavity twice, complicating interpretation of results—specifically, determining which fetus has the issue and whether selective reduction is necessary.
What does the amniocentesis procedure involve?
To minimize fetal injury risk, the amniotic sac's thickest area is targeted during amniocentesis, primarily avoiding the fetal head and eyes. Standard laboratory practices minimize infection risk through sterile techniques.The needle used for amniocentesis is very thin. If the pregnant woman can tolerate the sensation of a blood draw needle, she can usually tolerate the amniocentesis needle. For those experiencing significant anxiety or tension, local anesthesia can be administered. Lidocaine is injected at the puncture site to reduce discomfort.
During the procedure, an ultrasound machine with a sterile probe is used to visualize the baby's position. The needle and probe are operated simultaneously to ensure the depth of needle insertion is visible and to attempt a single, smooth insertion.Fetal heart rate is continuously monitored to confirm normality. Amniocentesis is a minimally invasive procedure typically taking 5 to 10 minutes. After the procedure, Doppler monitoring of the fetal heartbeat is required for 1 to 2 hours to confirm normal heart rate and absence of uterine contractions. Patients can usually return home afterward.